Traditional management of tuberculosis in ogun state of Nigeria: The practice and ethnobotanical survey

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 7, Issue 1, 2010, Pages 79-84

  Ogbole, Omonike O ^a   Ajaiyeoba, Edith O ^b  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Ethnobotany; Medicinal Plants; Ogun State; Traditional Management; Tuberculosis

Indexed keywords

HERBACEOUS AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AFRAMOMUM MELEGUETA; ARTICLE; COLA ACUMMINATA; CONTROLLED STUDY; COSTUS AFER; DISEASE PREDISPOSITION; DRUG RESEARCH; ETHNOBOTANY; FEMALE; GARCINIA KOLA; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; MEDICINAL PLANT; NIGERIA; PLANT LEAF; PLANT STEM; PRACTICE GUIDELINE; PYCNANTHUS ANGOLENSIS; SEX RATIO; TRADITIONAL MEDICINE; TREATMENT DURATION; TUBERCULOSIS; VITELLARIA PARADOXA;

EID: 77958072344     PISSN: 01896016     EISSN: 01896016     Source Type: Journal    
DOI: 10.4314/ajtcam.v7i1.57270     Document Type: Article

References (23)

1. Ajaiyeoba E, Ashidi J, Abiodun O, Okpako L, Ogbole O, Akinboye D, Falade C, Bolaji O, Gbotosho G, Falade M, Itiola O, Houghton P, Wright C, Oduola A. (2004). Anti-malarial Ethnobotany: in vitro antiplasmodial activity of seven plants identified in the Nigerian middle belt, J. Pharmaceut. Biol, 42 (8):588-591.
2. Ajaiyeoba EO, Ogbole OO, Ogundipe OO (2006). Ethnobotanical survey of Plants used in the traditional management of viral infections in Ogun State of Nigeria. Eur. J. Scientific Res., 13 (1):64-73.
3. Ajaiyeoba EO, Oladepo O, Fawole OI, Bolaji OM, Akinboye DO, Ogundahunsi OAT, Falade CO, Gbotosho GO, Itiola OA, Happi TC, Ebong OO, Ononiwu IM, Osowole OS, Oduola OO, Ashidi JS and Oduola AMJ (2003). Cultural categorization of febrile illnesses in correlation with herbal remedies used for treatment in Southwestern Nigeria, J. Ethnopharmacol., 85: 179-185.
4. Albers-Schonerg, G., Antoun, M., Gupta A, Burely J. and Sobrevila, C. (1997). Report of a special panel of experts on International Cooperation Biodiversity Groups (ICGB).Unpublished paper (http://www.nih.gov/fic/opportunities/-finalreport.html).
5. Berlin, B, Berlin, EA, Ugalde JCF, Barriors, LG, Puett D, Nash R. and Gonzalez-Espinoza R. (1994).The Maya ICGB: Drug discovery, medical ethnobiology, and alternative forms of economic development in the Highland Maya Region of Chiapas, Mexico. Pharmaceutic. Biol., 7:127-144.
6. Betti J L. (2004). An Ethnobotanical Study Of Medicinal Plants among The Baka Pygmies in the Dja Biosphere Reserve, Cameroon African Study Monographs, 25(1): 1-27.
7. Burkill, H.M. (1985). The useful plants of west tropical Africa, Vol. 1-5. Royal Botanic Gardens, Kew
8. Carvalho LH, Brandao MG and Santos-Filho H (1991). Antimalarial activity of crude extracts from Brazilian plants studied in vivo in Plasmodium berghei-infected mice & in vitro against Plasmodium falciparum in culture. Braz. J. Med. Biol. Res., 24(11):13-23.
9. Craigg, GM, Newman, DG and Snader KM. (1997). Natural products drug Discovery and Development. J. Nat Prod., 60:52-60.
10. Gautam, R.A. Saklani A, Jachak S.M, (2007), Indian medicinal plants as a source of antimycobacterial agent. J. Ethnopharmacol, 1109:200-234.
11. Girling, DJ. (1989). The chemotherapy of tuberculosis. The Biology of the Mycobacteria, 3: 43-47, Academic Press, London Book
12. Kumar P and Clark M. (2002). Respiratory diseases. Clinical Medicine, 134-156.
13. Levine A. (1981). The Mexican Plant zoapatle (Montanoa tomentosa) in Reproductive medicine. Past, Present and Future. J. Reprod. Med., 26:524-528.
14. Lewis W, Mutchler D., Castro N., Elvin-Lewis M. and Farnsworth N. (1998). Ethnomedicine, Chemistry and Biological Activity of South American Plants, 45-50 Chapman and Hull, London. Book.
15. Phillipson, JD. (1994). Natural Products as Drugs. Trans. R. Soc. Trop. Med. Hyg., 88:17-19.
16. Sanogo R, Drissa D, Abdoulaye S, Seydou D, Sergio G, Merlin W. (2006). Ethnobotanical study of plants used to treat TB in Mali, (http://www.oibc.org.uk/PastEvents/Symposium2007_files/Maliproject.ppt)
17. Sacchettini, J.C. Rubin E.J Freundich J.S (2008). Drugs versus bugs: in pursuit of the persistent predator mycobacterium tuberculosis, Nature Rev. Microbial., 6:41-52.
18. Storey, Christine and Salem, Júlia Ignez (1997). Lay use of Amazonian plants for the treatment of tuberculosis. Acta amaz, 27(3):175-82,
19. Tsukamura M (1985). In vitro anti tuberculosis, activity of a new antibacterial substance, ofloxacin (DL 8280). B: 348 Amer. Rev. Respir. Dis.,131(3): 348-351
20. WHO/IUATLD Working Group (1989). Tuberculosis and AIDS. Bull Intern. Union against Tuberculosis and Lung Disease. 64:8-11.
21. World Health Organization (2003). Treatemnt of Tuberculosis: Guidelines for National Programs. Edition 3, WHO, Geneva pp 1-113.
22. World Health Organisation, (2007). Global Tuberculosis Control: Surveillance Planning, Financing. WHO Report Geneva, Switzerland. (WHO/HTM/TB/2007.376)
23. World Health Organisation, (2008). Global Tuberculosis Control, WHO Report 2008, Country profile; Nigeria (WHO/HTM/TB/2008.